select a format

Single User License
USD 2500 INR 161975
Site License
USD 5000 INR 323950
Corporate User License
USD 7500 INR 485925

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2015

Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2591CTIDB
  • |
  • Pages: 79
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2015" provides data on the Subependymal Giant Cell Astrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Subependymal Giant Cell Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Subependymal Giant Cell Astrocytoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Subependymal Giant Cell Astrocytoma 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Five Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Clinical Trials by G7 Countries: Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials 12

Clinical Trials by Phase in G7 Countries 13

Clinical Trials in G7 Countries by Trial Status 14

Clinical Trials by E7 Countries: Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials 15

Clinical Trials in E7 Countries by Trial Status 16

Clinical Trials by Phase 17

In Progress Trials by Phase 18

Clinical Trials by Trial Status 19

Clinical Trials by End Point Status 20

Unaccomplished Trials of Subependymal Giant Cell Astrocytoma 21

Subjects Recruited Over a Period of Time 22

Clinical Trials by Sponsor Type 23

Prominent Sponsors 24

Prominent Drugs 25

Clinical Trial Profiles 26

Clinical Trial Overview of Top Companies 26

Novartis AG 26

Clinical Trial Overview of Novartis AG 26

Clinical Trial Overview of Top Institutes / Government 27

National Cancer Institute 27

Clinical Trial Overview of National Cancer Institute 27

Cincinnati Children's Hospital Medical Center 28

Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 28

Societe Internationale d'Oncologie Pediatrique 29

Clinical Trial Overview of Societe Internationale d'Oncologie Pediatrique 29

Thomas Jefferson University 30

Clinical Trial Overview of Thomas Jefferson University 30

Barbara Ann Karmanos Cancer Institute 31

Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 31

Five Key Clinical Profiles 32

Appendix 76

Abbreviations 76

Definitions 76

Research Methodology 77

Secondary Research 77

About GlobalData 78

Contact Us 78

Disclaimer 78

Source 79

List of Figures

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11

Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials, G7 Countries (%), 2015* 12

Subependymal Giant Cell Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Subependymal Giant Cell Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials, E7 Countries (%), 2015* 15

Subependymal Giant Cell Astrocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 16

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Subependymal Giant Cell Astrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

GlobalData Methodology 77

List of Tables

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Region, 2015* 6

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials, G7 Countries (%), 2015* 12

Subependymal Giant Cell Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Subependymal Giant Cell Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials, E7 Countries (%), 2015* 15

Subependymal Giant Cell Astrocytoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 16

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Phase, 2015* 17

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Terminated Clinical Trials, 2015* 21

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22

Subependymal Giant Cell Astrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 26

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 27

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2015* 28

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Societe Internationale d'Oncologie Pediatrique, 2015* 29

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015* 30

Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2015* 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Subependymal Giant Cell Astrocytoma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Subependymal Giant Cell Astrocytoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com